1. Home
  2. BNR vs AHT Comparison

BNR vs AHT Comparison

Compare BNR & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • AHT
  • Stock Information
  • Founded
  • BNR 2014
  • AHT 2003
  • Country
  • BNR China
  • AHT United States
  • Employees
  • BNR N/A
  • AHT N/A
  • Industry
  • BNR Medical Specialities
  • AHT Real Estate Investment Trusts
  • Sector
  • BNR Health Care
  • AHT Real Estate
  • Exchange
  • BNR Nasdaq
  • AHT Nasdaq
  • Market Cap
  • BNR 38.3M
  • AHT 36.7M
  • IPO Year
  • BNR 2020
  • AHT 2003
  • Fundamental
  • Price
  • BNR $8.37
  • AHT $6.20
  • Analyst Decision
  • BNR
  • AHT
  • Analyst Count
  • BNR 0
  • AHT 0
  • Target Price
  • BNR N/A
  • AHT N/A
  • AVG Volume (30 Days)
  • BNR 38.7K
  • AHT 39.1K
  • Earning Date
  • BNR 09-08-2025
  • AHT 11-04-2025
  • Dividend Yield
  • BNR N/A
  • AHT N/A
  • EPS Growth
  • BNR N/A
  • AHT N/A
  • EPS
  • BNR N/A
  • AHT N/A
  • Revenue
  • BNR $74,862,782.00
  • AHT $1,129,379,000.00
  • Revenue This Year
  • BNR $136.32
  • AHT N/A
  • Revenue Next Year
  • BNR N/A
  • AHT N/A
  • P/E Ratio
  • BNR N/A
  • AHT N/A
  • Revenue Growth
  • BNR 5.20
  • AHT N/A
  • 52 Week Low
  • BNR $2.18
  • AHT $5.20
  • 52 Week High
  • BNR $11.12
  • AHT $11.99
  • Technical
  • Relative Strength Index (RSI)
  • BNR 51.90
  • AHT 51.71
  • Support Level
  • BNR $8.02
  • AHT $6.00
  • Resistance Level
  • BNR $9.55
  • AHT $6.44
  • Average True Range (ATR)
  • BNR 0.67
  • AHT 0.18
  • MACD
  • BNR -0.15
  • AHT 0.02
  • Stochastic Oscillator
  • BNR 30.29
  • AHT 60.66

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks: